Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Cancer. 2011 Jul 11;117(23):5392–5401. doi: 10.1002/cncr.26198

Table 3.

Progressive relaxation of guidelines depicting the number of subjects in receipt of compliant care and the number of providers who delivered compliant care to at least one patient.

Compliance criteria Subjects (n=4545)
n (%)
Providers (n=1536)
n (%)
≥8 Cystoscopy and ≥8 Cytology and ≥6 BCG 19 (0.4%) 16 (1.0%)
≥8 Cystoscopy and ≥8 Cytology and ≥1 BCG 23 (0.5%) 22 (1.4%)
≥8 Cystoscopy and ≥4 Cytology and ≥6 BCG 42 (0.9%) 40 (2.6%)
≥4 Cystoscopy and ≥4 Cytology and ≥6 BCG 597 (13.1%) 398 (25.9%)
≥4 Cystoscopy and ≥4 Cytology and ≥1 BCG 799 (17.6%) 479 (31.2%)
≥4 Cystoscopy and ≥1 Cytology and ≥1 BCG 1527 (33.6%) 823 (53.6%)
≥1 Cystoscopy and ≥1 Cytology and ≥1 BCG 1703 (37.5%) 891 (58.0%)
≥1 Cystoscopy and ≥1 BCG 2437 (53.6%) 1148 (74.7%)
≥1 Cystoscopy 4373 (96.2%) 1510 (98.3%)